{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T07:37:36Z","timestamp":1776065856600,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,1,25]],"date-time":"2022-01-25T00:00:00Z","timestamp":1643068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,25]],"date-time":"2022-01-25T00:00:00Z","timestamp":1643068800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"published-print":{"date-parts":[[2022,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Portal vein thrombosis (PVT) and venous thromboembolism (VTE) are fearsome complications of liver cirrhosis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Objectives<\/jats:title>\n                <jats:p>To assess the prevalence and the main risk factors for venous thrombotic complications in hospitalized cirrhotic patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Patients\/methods<\/jats:title>\n                <jats:p>We retrospectively reviewed electronic administrative discharge data of 19461\u00a0cirrhotic patients hospitalized over a 35-year period; univariate and multivariate logistic regression was used to asses risk factors for PVT or VTE and their impact on hospital stay and mortality.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>382 out of 7445 patients (5.1%) were diagnosed with PVT and 95 (1.3%) with VTE. Liver cirrhosis complications were observed in 45% of patients. Hepatic encephalopathy (HE) (OR 13.88 [10.76\u201317.98] <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001), endoscopic signs of portal hypertension (OR 1.33 [1.02\u20131.75] <jats:italic>p<\/jats:italic>\u2009=\u20090.02), hepatocellular carcinoma (HCC) (OR 4.59 [3.6\u20135.84] <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001), diabetes (OR 1.68 [1.27\u20132.22] <jats:italic>p<\/jats:italic>\u2009=\u20090.0001), abdominal surgery\/invasive procedures (OR 2.03 [1.56\u20132.64] <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001) emerged as independent predictors of PVT. Higher risk of VTE was observed in patients with HE (OR 3.21 [1.78\u20135.79] <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001), HCC (OR 1.98 [1.23\u20133.19] <jats:italic>p<\/jats:italic>\u2009=\u20090.002) or other tumors (OR 2.48 [1.42\u20134.32] <jats:italic>p<\/jats:italic>\u2009=\u20090.001), acute illnesses (infections OR 3.01 [1.84\u20135.05] <jats:italic>p<\/jats:italic>\u2009=\u20090.0001; cardiac\/respiratory insufficiency OR 2.4 [1.27\u20134.53] <jats:italic>p<\/jats:italic>\u2009=\u20090.003; acute myocardial infarction\/stroke OR 7.86 [1.76\u201335.12] <jats:italic>p<\/jats:italic>\u2009=\u20090.003). VTE was the only independent predictor of in-hospital mortality (OR 4.45 [1.05\u201318.81] <jats:italic>p<\/jats:italic>\u2009=\u20090.042).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Liver disease complications related to portal hypertension, HCC or other tumors, diabetes, acute illnesses (i.e. infections, cardiac\/pulmonary insufficiency, acute myocardial infarction\/stroke) and abdominal interventions are associated with increased risk of PVT or VTE in hospitalized cirrhotic patients, and should be considered to define personalized preemptive\u00a0approaches.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s11739-022-02928-8","type":"journal-article","created":{"date-parts":[[2022,1,25]],"date-time":"2022-01-25T10:04:02Z","timestamp":1643105042000},"page":"1327-1334","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Risk factors for portal vein thrombosis or venous thromboembolism in a large cohort of hospitalized cirrhotic patients"],"prefix":"10.1007","volume":"17","author":[{"given":"Mariella","family":"Faccia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Santopaolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Gasbarrini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Pompili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Assunta","family":"Zocco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5924-6238","authenticated-orcid":false,"given":"Francesca Romana","family":"Ponziani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,25]]},"reference":[{"key":"2928_CR1","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1056\/NEJMra1011170","volume":"365","author":"A Tripodi","year":"2011","unstructured":"Tripodi A, Mannucci PM (2011) The coagulopathy of chronic liver disease. N Engl J Med 365:147\u2013156. https:\/\/doi.org\/10.1056\/NEJMra1011170","journal-title":"N Engl J Med"},{"key":"2928_CR2","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.jhep.2009.03.013","volume":"51","author":"MA Zocco","year":"2009","unstructured":"Zocco MA, Di Stasio E, De Cristofaro R et al (2009) Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development. J Hepatol 51:682\u2013689. https:\/\/doi.org\/10.1016\/j.jhep.2009.03.013","journal-title":"J Hepatol"},{"key":"2928_CR3","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.trre.2014.01.003","volume":"28","author":"FR Ponziani","year":"2014","unstructured":"Ponziani FR, Zocco MA, Senzolo M et al (2014) Portal vein thrombosis and liver transplantation: implications for waiting list period, surgical approach, early and late follow-up. Transplant Rev (Orlando) 28:92\u2013101. https:\/\/doi.org\/10.1016\/j.trre.2014.01.003","journal-title":"Transplant Rev (Orlando)"},{"key":"2928_CR4","doi-asserted-by":"publisher","first-page":"4437","DOI":"10.3748\/wjg.v25.i31.4437","volume":"25","author":"M Faccia","year":"2019","unstructured":"Faccia M, Ainora ME, Ponziani FR et al (2019) Portal vein thrombosis in cirrhosis: Why a well-known complication is still matter of debate. World J Gastroenterol 25:4437\u20134451. https:\/\/doi.org\/10.3748\/wjg.v25.i31.4437","journal-title":"World J Gastroenterol"},{"key":"2928_CR5","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3748\/wjg.v16.i2.143","volume":"16","author":"FR Ponziani","year":"2010","unstructured":"Ponziani FR, Zocco MA, Campanale C et al (2010) Portal vein thrombosis: insight into physiopathology, diagnosis, and treatment. World J Gastroenterol 16:143\u2013155. https:\/\/doi.org\/10.3748\/wjg.v16.i2.143","journal-title":"World J Gastroenterol"},{"key":"2928_CR6","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1016\/j.thromres.2014.09.031","volume":"134","author":"H Bogari","year":"2014","unstructured":"Bogari H, Patanwala AE, Cosgrove R, Katz M (2014) Risk-assessment and pharmacological prophylaxis of venous thromboembolism in hospitalized patients with chronic liver disease. Thromb Res 134:1220\u20131223. https:\/\/doi.org\/10.1016\/j.thromres.2014.09.031","journal-title":"Thromb Res"},{"key":"2928_CR7","doi-asserted-by":"publisher","first-page":"E450","DOI":"10.3390\/cancers10110450","volume":"10","author":"A Zanetto","year":"2018","unstructured":"Zanetto A, Campello E, Spiezia L et al (2018) Cancer-associated thrombosis in cirrhotic patients with hepatocellular carcinoma. Cancers (Basel) 10:E450. https:\/\/doi.org\/10.3390\/cancers10110450","journal-title":"Cancers (Basel)"},{"key":"2928_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/ctg.2015.27","volume":"6","author":"KK S\u00f8gaard","year":"2015","unstructured":"S\u00f8gaard KK, Horv\u00e1th-Puh\u00f3 E, Montomoli J et al (2015) Cirrhosis is associated with an increased 30-day mortality after venous thromboembolism. Clin Transl Gastroenterol 6:e97. https:\/\/doi.org\/10.1038\/ctg.2015.27","journal-title":"Clin Transl Gastroenterol"},{"key":"2928_CR9","unstructured":"Liver cirrhosis is associated with venous thromboembolism among hospitalized patients in a nationwide US study\u2014PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/20566312\/. Accessed 8 Sept 2021"},{"key":"2928_CR10","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373\u2013383. https:\/\/doi.org\/10.1016\/0021-9681(87)90171-8","journal-title":"J Chronic Dis"},{"key":"2928_CR11","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1148\/radiol.12112236","volume":"265","author":"A Luca","year":"2012","unstructured":"Luca A, Caruso S, Milazzo M et al (2012) Natural course of extrahepatic nonmalignant partial portal vein thrombosis in patients with cirrhosis. Radiology 265:124\u2013132. https:\/\/doi.org\/10.1148\/radiol.12112236","journal-title":"Radiology"},{"key":"2928_CR12","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1111\/tri.13353","volume":"31","author":"A Zanetto","year":"2018","unstructured":"Zanetto A, Rodriguez-Kastro K-I, Germani G et al (2018) Mortality in liver transplant recipients with portal vein thrombosis\u2014an updated meta-analysis. Transpl Int 31:1318\u20131329. https:\/\/doi.org\/10.1111\/tri.13353","journal-title":"Transpl Int"},{"key":"2928_CR13","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.jhep.2021.04.029","volume":"75","author":"M Senzolo","year":"2021","unstructured":"Senzolo M, Garcia-Tsao G, Garc\u00eda-Pag\u00e1n JC (2021) Current knowledge and management of portal vein thrombosis in cirrhosis. J Hepatol 75:442\u2013453. https:\/\/doi.org\/10.1016\/j.jhep.2021.04.029","journal-title":"J Hepatol"},{"key":"2928_CR14","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.transproceed.2012.01.131","volume":"44","author":"G Grosso","year":"2012","unstructured":"Grosso G, di Francesco F, Vizzini G et al (2012) The Charlson comorbidity index as a predictor of outcomes in liver transplantation: single-center experience. Transplant Proc 44:1298\u20131302. https:\/\/doi.org\/10.1016\/j.transproceed.2012.01.131","journal-title":"Transplant Proc"},{"key":"2928_CR15","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1111\/j.1538-7836.2010.04044.x","volume":"8","author":"S Barbar","year":"2010","unstructured":"Barbar S, Noventa F, Rossetto V et al (2010) A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score. J Thromb Haemost 8:2450\u20132457. https:\/\/doi.org\/10.1111\/j.1538-7836.2010.04044.x","journal-title":"J Thromb Haemost"},{"key":"2928_CR16","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1136\/gut.2004.042796","volume":"54","author":"C Francoz","year":"2005","unstructured":"Francoz C, Belghiti J, Vilgrain V et al (2005) Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation. Gut 54:691\u2013697. https:\/\/doi.org\/10.1136\/gut.2004.042796","journal-title":"Gut"},{"key":"2928_CR17","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/BF02208603","volume":"41","author":"D Politoske","year":"1996","unstructured":"Politoske D, Ralls P, Korula J (1996) Portal vein thrombosis following endoscopic variceal sclerotherapy. Prospective controlled comparison in patients with cirrhosis. Dig Dis Sci 41:185\u2013190. https:\/\/doi.org\/10.1007\/BF02208603","journal-title":"Dig Dis Sci"},{"key":"2928_CR18","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1007\/s10620-011-1582-5","volume":"56","author":"M Ali","year":"2011","unstructured":"Ali M, Ananthakrishnan AN, McGinley EL, Saeian K (2011) Deep vein thrombosis and pulmonary embolism in hospitalized patients with cirrhosis: a nationwide analysis. Dig Dis Sci 56:2152\u20132159. https:\/\/doi.org\/10.1007\/s10620-011-1582-5","journal-title":"Dig Dis Sci"},{"key":"2928_CR19","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1097\/00005792-199909000-00001","volume":"78","author":"N Levitan","year":"1999","unstructured":"Levitan N, Dowlati A, Remick SC et al (1999) Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data. Medicine (Baltimore) 78:285\u2013291. https:\/\/doi.org\/10.1097\/00005792-199909000-00001","journal-title":"Medicine (Baltimore)"},{"key":"2928_CR20","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.dld.2016.12.019","volume":"49","author":"A Zanetto","year":"2017","unstructured":"Zanetto A, Senzolo M, Vitale A et al (2017) Thromboelastometry hypercoagulable profiles and portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma. Dig Liver Dis 49:440\u2013445. https:\/\/doi.org\/10.1016\/j.dld.2016.12.019","journal-title":"Dig Liver Dis"},{"key":"2928_CR21","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1097\/SLA.0b013e318206818b","volume":"253","author":"M Ravaioli","year":"2011","unstructured":"Ravaioli M, Zanello M, Grazi GL et al (2011) Portal vein thrombosis and liver transplantation: evolution during 10 years of experience at the University of Bologna. Ann Surg 253:378\u2013384. https:\/\/doi.org\/10.1097\/SLA.0b013e318206818b","journal-title":"Ann Surg"},{"key":"2928_CR22","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1097\/00007890-199404270-00006","volume":"57","author":"BR Davidson","year":"1994","unstructured":"Davidson BR, Gibson M, Dick R et al (1994) Incidence, risk factors, management, and outcome of portal vein abnormalities at orthotopic liver transplantation. Transplantation 57:1174\u20131177. https:\/\/doi.org\/10.1097\/00007890-199404270-00006","journal-title":"Transplantation"},{"key":"2928_CR23","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1002\/lt.24134","volume":"21","author":"JG Stine","year":"2015","unstructured":"Stine JG, Shah NL, Argo CK et al (2015) Increased risk of portal vein thrombosis in patients with cirrhosis due to nonalcoholic steatohepatitis. Liver Transpl 21:1016\u20131021. https:\/\/doi.org\/10.1002\/lt.24134","journal-title":"Liver Transpl"},{"issue":"Suppl 1","key":"2928_CR24","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1080\/07357900802656681","volume":"27","author":"T Wun","year":"2009","unstructured":"Wun T, White RH (2009) Venous thromboembolism (VTE) in patients with cancer: epidemiology and risk factors. Cancer Investig 27(Suppl 1):63\u201374. https:\/\/doi.org\/10.1080\/07357900802656681","journal-title":"Cancer Investig"},{"key":"2928_CR25","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1038\/sj.bjc.6605883","volume":"103","author":"DP Cronin-Fenton","year":"2010","unstructured":"Cronin-Fenton DP, S\u00f8ndergaard F, Pedersen LA et al (2010) Hospitalisation for venous thromboembolism in cancer patients and the general population: a population-based cohort study in Denmark, 1997\u20132006. Br J Cancer 103:947\u2013953. https:\/\/doi.org\/10.1038\/sj.bjc.6605883","journal-title":"Br J Cancer"},{"key":"2928_CR26","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S0140-6736(20)32658-1","volume":"398","author":"F Khan","year":"2021","unstructured":"Khan F, Tritschler T, Kahn SR, Rodger MA (2021) Venous thromboembolism. Lancet 398:64\u201377. https:\/\/doi.org\/10.1016\/S0140-6736(20)32658-1","journal-title":"Lancet"},{"key":"2928_CR27","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1161\/ATVBAHA.114.304085","volume":"34","author":"W Ageno","year":"2014","unstructured":"Ageno W, Di Minno MND, Ay C et al (2014) Association between the metabolic syndrome, its individual components, and unprovoked venous thromboembolism: results of a patient-level meta-analysis. Arterioscler Thromb Vasc Biol 34:2478\u20132485. https:\/\/doi.org\/10.1161\/ATVBAHA.114.304085","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2928_CR28","doi-asserted-by":"publisher","DOI":"10.1055\/a-1667-7293","author":"T-W Ow","year":"2021","unstructured":"Ow T-W, Fatourou E, Rabinowich L et al (2021) Prevalence of bleeding and thrombosis in critically ill patients with chronic liver disease. Thromb Haemost. https:\/\/doi.org\/10.1055\/a-1667-7293","journal-title":"Thromb Haemost"},{"key":"2928_CR29","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jhep.2014.03.013","volume":"61","author":"A Tripodi","year":"2014","unstructured":"Tripodi A, Fracanzani AL, Primignani M et al (2014) Procoagulant imbalance in patients with non-alcoholic fatty liver disease. J Hepatol 61:148\u2013154. https:\/\/doi.org\/10.1016\/j.jhep.2014.03.013","journal-title":"J Hepatol"},{"key":"2928_CR30","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/hep.26510","volume":"59","author":"A Verrijken","year":"2014","unstructured":"Verrijken A, Francque S, Mertens I et al (2014) Prothrombotic factors in histologically proven nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Hepatology 59:121\u2013129. https:\/\/doi.org\/10.1002\/hep.26510","journal-title":"Hepatology"},{"key":"2928_CR31","doi-asserted-by":"publisher","first-page":"183","DOI":"10.2174\/187152511797037448","volume":"9","author":"FR Ponziani","year":"2011","unstructured":"Ponziani FR, Zocco MA, Tortora A et al (2011) Anticoagulants in cirrhotic patients: controversies and certainties in PVT management. Cardiovasc Hematol Agents Med Chem 9:183\u2013189. https:\/\/doi.org\/10.2174\/187152511797037448","journal-title":"Cardiovasc Hematol Agents Med Chem"},{"key":"2928_CR32","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1177\/0897190015611570","volume":"30","author":"KJ Moorehead","year":"2017","unstructured":"Moorehead KJ, Jeffres MN, Mueller SW (2017) A retrospective cohort analysis of pharmacologic VTE prophylaxis and padua prediction score in hospitalized patients with chronic liver disease. J Pharm Pract 30:58\u201363. https:\/\/doi.org\/10.1177\/0897190015611570","journal-title":"J Pharm Pract"},{"key":"2928_CR33","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/j.1365-2036.2007.03572.x","volume":"27","author":"JR Kramer","year":"2008","unstructured":"Kramer JR, Davila JA, Miller ED et al (2008) The validity of viral hepatitis and chronic liver disease diagnoses in veterans affairs administrative databases. Aliment Pharmacol Ther 27:274\u2013282. https:\/\/doi.org\/10.1111\/j.1365-2036.2007.03572.x","journal-title":"Aliment Pharmacol Ther"},{"key":"2928_CR34","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1007\/s10620-017-4503-4","volume":"62","author":"R Omino","year":"2017","unstructured":"Omino R, Mittal S, Kramer JR et al (2017) The validity of HCC diagnosis codes in chronic hepatitis B patients in the Veterans Health Administration. Dig Dis Sci 62:1180\u20131185. https:\/\/doi.org\/10.1007\/s10620-017-4503-4","journal-title":"Dig Dis Sci"},{"key":"2928_CR35","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.thromres.2010.03.009","volume":"126","author":"RH White","year":"2010","unstructured":"White RH, Garcia M, Sadeghi B et al (2010) Evaluation of the predictive value of ICD-9-CM coded administrative data for venous thromboembolism in the United States. Thromb Res 126:61\u201367. https:\/\/doi.org\/10.1016\/j.thromres.2010.03.009","journal-title":"Thromb Res"},{"key":"2928_CR36","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000009960","volume":"97","author":"EM Ammann","year":"2018","unstructured":"Ammann EM, Cuker A, Carnahan RM et al (2018) Chart validation of inpatient International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) administrative diagnosis codes for venous thromboembolism (VTE) among intravenous immune globulin (IGIV) users in the Sentinel Distributed Database. Medicine (Baltimore) 97:e9960. https:\/\/doi.org\/10.1097\/MD.0000000000009960","journal-title":"Medicine (Baltimore)"},{"key":"2928_CR37","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.jhepr.2019.02.006","volume":"1","author":"L Turco","year":"2019","unstructured":"Turco L, de Raucourt E, Valla D-C, Villa E (2019) Anticoagulation in the cirrhotic patient. JHEP Rep 1:227\u2013239. https:\/\/doi.org\/10.1016\/j.jhepr.2019.02.006","journal-title":"JHEP Rep"}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-022-02928-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11739-022-02928-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-022-02928-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T08:20:07Z","timestamp":1659601207000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11739-022-02928-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,25]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["2928"],"URL":"https:\/\/doi.org\/10.1007\/s11739-022-02928-8","relation":{},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"value":"1828-0447","type":"print"},{"value":"1970-9366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,25]]},"assertion":[{"value":"1 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in this study were in accordance with the ethical standards of the institutional research committee (approval ID 3394) and with the 1964 Helsinki declaration and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"For this retrospective study, formal consent was not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}